StockStory.org on MSN13d
Privia Health (NASDAQ:PRVA) Surprises With Q4 Sales But Full-Year Sales Guidance Misses Expectations
Healthcare tech company Privia Health Group (NASDAQ:PRVA) announced in Q4 CY2024, with sales up 4.6% year on year to $460.9 ...
Privia Health price target raised to $40 from $25 at Piper Sandler
Piper Sandler raised the firm’s price target on Privia Health (PRVA) to $40 from $25 and keeps an Overweight rating on the shares. In the ...
Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results
Operating and Financial Metrics Above High End of Guidance RangesVery strong New Provider Signings with Implemented Providers +11.2% ...